Multicenter Comparison of Clotrimazole Vaginal Tablets, Oral Metronidazole, and Vaginal Suppositories Containing Sulfanilamide, Aminacrine Hydrochloride, and Allantoin in the Treatment of Symptomatic Trichomoniasis

@article{duBOUCHET1997MulticenterCO,
  title={Multicenter Comparison of Clotrimazole Vaginal Tablets, Oral Metronidazole, and Vaginal Suppositories Containing Sulfanilamide, Aminacrine Hydrochloride, and Allantoin in the Treatment of Symptomatic Trichomoniasis},
  author={Lorraine duBOUCHET and Michael R. Spence and Michael F. Rein and Melvyn R. Danzig and William M. Mccormack},
  journal={Sexually Transmitted Diseases},
  year={1997},
  volume={24},
  pages={156–160}
}
Background and Objectives: Trichomonas vaginalis is a common vaginal pathogen. Oral metronidazole is the drug of choice for the treatment of trichomoniasis. Oral metronidazole, however, may cause unpleasant side effects and is contraindicated during the first trimester of pregnancy. In vitro studies and preliminary clinical data have suggested that intravaginal clotrimazole may be effective against this pathogen. Goals: To compare the efficacy of clotrimazole vaginal tablets, oral metronidazole… 

A Pilot Study of Metronidazole Vaginal Gel Versus Oral Metronidazole for the Treatment of Trichomonas vaginalis Vaginitis

0.75% metronidazole vaginal gel is not effective as a single agent for the treatment of trichomoniasis, and future studies may define a role for metronidsazole gel for symptomatic relief in patients intolerant of oral medication.

Single-Dose Compared With Multidose Metronidazole for the Treatment of Trichomoniasis in Women: A Meta-Analysis

Treatment failure between single versus multidose metronidazole for the treatment of T. vaginalis is compared to suggest that treatment recommendations for HIV+ women to multidosing rather than single-dose should be considered for all women.

Efficacy and tolerability of two intravaginal formulations containing clindamycin plus clotrimazole in women with vaginal infections: A pilot study

Both formulations containing clindamycin plus clotrimazole were effective, as empiric therapy, in inducing and maintaining microbiological as well as clinical remission in women with clinical diagnosis of vaginal infection to a similar extent but should not to be recommended for cases specifically identified to have trichomoniasis.

Diagnosis and Treatment of Metronidazole-Resistant Trichomonas vaginalis Infection

T. vaginalis infections not responding to 5-nitroimidazole drugs used for standard therapy is a concern for adult sexual health due to persistence of infection and its complications as well as the risk for increased spread of disease due to clinical symptom relief following treatment without microbiological cure.

A Randomized Treatment Trial: Single Versus 7-Day Dose of Metronidazole for The Treatment of Trichomonas Vaginalis Among HIV-Infected Women

The 7-day MTZ dose was more effective than the single dose for the treatment of TV among HIV+ women.

Management of vaginitis.

Topical azole and oral fluconazole are equally efficacious in the management of uncomplicated vulvovaginal candidiasis, but a more extensive regimen may be required for complicated infections.

Oral Metronidazole Desensitization for Immunoglobulin E (IgE)-Mediated Hypersensitivity

Physicians may use a desensitization protocol for patients with a presumed IgE-mediated hypersensitivity when only the 5-nitroimidazole class is efficacious for the treatment of trichomoniasis.

Does Antiretroviral Therapy Interfere With the Treatment of Trichomonas vaginalis Among HIV+ Women?

The 2 g single dose MTZ treatment success rate among HIV+ women, was significantly lower for those with bacterial vaginosis (BV, corroborating the findings of Balkus et al, however, it was found that women who were receiving antiretroviral therapy (ART) also had lower treatment success.

Zinc-clotrimazole complexes are effective against Trichomonas vaginalis

[Zn(CTZ)2(Ac)2] is found to be a highly effective compound against T. vaginalis in vitro, suggesting its potential utility as an alternative chemotherapy for trichomoniasis.

References

SHOWING 1-4 OF 4 REFERENCES

Evaluation of two serological tests for Trichomonas vaginalis infection

Serological methods can provide a rapid, sensitive, and economical tool to study the epidemiology of this common protozoan infection, and are confirmed to have the specificity of the test.

The retail pharmacist

Though the exclusive use of approved names would simplify dispensing by a retail pharmacist, present standards of equivalence are not adequate to ensure that in these circumstances the patient would